Cargando…
Potential risk of drug–drug interactions with hormonal contraceptives and antiretrovirals: prevalence in women living with HIV
BACKGROUND: Family planning services are vital for women living with HIV (WLH); however, the use of concomitant antiretroviral therapy (ART) and hormonal contraceptives (HCs) may pose challenges due to the risk of potential drug–drug interactions (DDIs). The objectives of this study were to assess A...
Autores principales: | Murray, Milena M, Jensen, Ashley, Cieslik, Thomas, Cohn, Susan E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413590/ https://www.ncbi.nlm.nih.gov/pubmed/32821262 http://dx.doi.org/10.7573/dic.2020-5-9 |
Ejemplares similares
-
Prevalence of Drug–Drug Interactions with Hormonal Contraceptives and Antiretrovirals in Women Living with HIV
por: McLaughlin, Milena M, et al.
Publicado: (2017) -
Drug interactions between hormonal contraceptives and antiretrovirals
por: Nanda, Kavita, et al.
Publicado: (2017) -
Contraception for the HIV-Positive Woman: A Review of Interactions between Hormonal Contraception and Antiretroviral Therapy
por: Robinson, Jennifer A., et al.
Publicado: (2012) -
Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?
por: Bukkems, Vera E., et al.
Publicado: (2020) -
Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain
por: Castro-Granell, Vanessa, et al.
Publicado: (2021)